Matrix metalloproteinase-1 and -3 in breast cancer: Correlation with progesterone receptors and other clinicopathologic features

Human Pathology

Volumn 30, Issue 4, 1999, Pages 436-442

  Nakopoulou, Lydia ^a   Giannopoulou, Ioanna ^b   Gakiopoulou, Hariklia ^b   Liapis, Helen ^b   Tzonou, Anastasia ^b   Davaris, Panagiotis S ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

Breast cancer; MMP 1; MMP 3; MMP 3 mRNA; Progesterone receptors

Indexed keywords

COLLAGENASE; ESTROGEN RECEPTOR; MESSENGER RNA; ONCOPROTEIN; PROGESTERONE RECEPTOR; STROMELYSIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL EXAMINATION; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; STATISTICAL ANALYSIS;

EID: 0032917513     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90120-X     Document Type: Article

References (43)

1. Liotta LA: Tumor invasion and metastasis: Role of extracellular matrix. Cancer Res 46:1-7, 1986
2. Powell WC, Matrisian LM: Complex roles of matrix metalloproteinases in tumor progression: Attempts to understand metastasis formation, in Gunthert U, Schlag PM, Birchmeier W (eds): Metastasis Related Molecules. Heidelberg, Germany, Springer-Verlag, 1996, pp 1-21
3. Chen WT: Membrane proteases: Roles in tissue remodeling and tumor invasion. Curr Opin Cell Biol 4:802-809, 1992
4. Nagase H, Suzuki K, Morodomi T, et al: Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix 1:237-244, 1992 (suppl)
5. Diaz-Meco MT, Quinones S, Municio MM, et al: Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene and phosphatidylcholine-hybridyzing phospholipase. C J Biol Chem 266:22597-22602, 1991
6. Case JP, Lafyatis R, Kumkumian GK, et al: IL-1 regulation of transin stromelysin transcription in rheumatoid synovial fibroblasts appears to involve two antagonistic transcription pathways, an inhibitory, prostaglandin-dependent pathway mediated by cAMP, and a stimulatory, protein kinase C-dependent pathway. J Immunol 145: 3755-3761, 1990
7. Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581-3584, 1992
8. Woolley DE, Tetlow LC, Evanson JM: Collagenases immunolocalization studies of rheumatoid and malignant tissue, in Wooley DE, Evanson JM (eds): Collagenases in Normal and Pathological Connective Tissues, Winchester, England, Wiley, 1980, pp 143-148
9. Okada Y, Nagase H, Harris ED: A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J Biol Chem 261:14245-14255, 1986
10. Werb Z, Sympson CJ, Alexander CM, et al: Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int 54:568-574, 1996 (suppl)
11. Lund LR, Romer J, Thomasset N, et al: Two distinct phases of apoptosis in mammary gland involution. Development 122:181-193, 1996
12. Terada T, Okada Y, Nakanuma Y: Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 23:1341-1344, 1996
13. Sakurai Y, Otani Y, Kameyama K, et al: Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers. Jpn J Cancer Res 88:401-406, 1997
14. Bramhall SR, Neoptolemos JP, Stamp GW, et al: Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182:347-355, 1997
15. Shima I, Sasaguri Y, Kusukawa J, et al: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. Cancer 70:2747-2753, 1992
16. Urbanski SJ, Edwards DR, Maitland A, et al: Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66:1188-1194, 1992
17. Alessandro R, Minafra S, Pucci-Minafra I, et al: Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer 55:250-255, 1993
18. Ito A, Nakajima S, Sasaguri Y, et al: Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71:1039-1045, 1995
19. Chenard MP, O'Siorain L, Shering S, et al: High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 69:448-451, 1996
20. Lee KS, Rha SY, Kim SJ, et al: Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis 14:512-519, 1996
21. World Health Organization: International Histological Classification of Tumors. Histological Typing of Breast Tumors, No 2 (ed 2). Geneva, Switzerland, WHO, 1981, pp 1-29
22. International Union Against Cancer, in Hermanek P, Sobin LH (eds): TNM Classification of Malignant Tumors (ed 4, fully revised edition). Berlin, Germany, International Union Against Cancer Geneva, 1987, pp 93-99
23. Elston CW: Grading of invasive carcinoma of the breast, in Page DL, Anderson IJ (eds): Diagnostic Histopathology of the Breast. Edinburgh, Scotland, Churchill-Livingstone, 1987, pp 300-311
24. Hsu SM, Raine L, Fanger H: The use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
25. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, et al: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 94:79-88, 1994
26. Liapis H, Crouch EC, Grosso LE, et al: Expression of parathyroid like protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 143:1169-1178, 1993
27. Armitage P, Berry G: Statistical Methods in Medical Research (ed 2). Oxford, England, Blackwell Scientific Publications, 1987, pp 296-312
28. Polette M, Clavel C, Cockett M, et al: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13:31-37, 1993
29. Kawami H, Yoshida K, Ohsaki A, et al: Stromelysin-3 mRNA expression and malignancy: Comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors. Anticancer Res 13:2319-2324, 1993
30. Murphy G, Cockett MI, Sephens PE, et al: Stromelysin is an activator of procollagenase: A study with natural and recombinant enzymes. Biochem J 248:265-268, 1987
31. Lochter A, Galosy S, Muschler J, et al: Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial to mesenchymal conversion and a premalignant phenotype, in mammary epithelial cells. J Cell Biol 139:1861-1872, 1997
32. Jonat C, Rahmsdorf HJ, Park KK, et al: Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204, 1990
33. Bruner KL, Rodgers WH, Gold LI, et al: Transforming growth factor-β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 92:7362-7366, 1995
34. Salamonsen LA, Butt AR, Hammond R, et al: Production of endometrial matrix metalloproteinases, but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 78:1409-1415, 1997
35. Hahnel E, HarveyJM, Joyce R, et al: Stromelysin-3 expression in breast cancer biopsies: Clinicopathological correlations. Int J Cancer 55:771-774, 1993
36. Engel G, Heselmeyer K, Auer G, et al: Correlation between stromelysin-3 mRNA levels and outcome of human breast cancer. IntJ Cancer 58:830-835, 1994
37. Muller D, Wolf C, Abecassis J, et al: Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53:165-169, 1993
38. Newek JH, Witty JP, Rodgers WH, et al: Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10:199-206, 1994
39. Clavel C, Polette M, Doco M, et al: Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bull Cancer 79:261-270, 1992
40. Emonard HP, Remade AG, Noel AC, et al: Tumor cell surface-associated binding site for the Mr 72.000 type PV collagenase. Cancer Res 52:5845-5848, 1992
41. Polette M, Gilbert N, Stas I, et al: Gelatinase A expression and localization in human breast cancers: An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch Int J Pathol 424:641-645, 1994
42. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-64, 1994
43. Okada A, Bellocq J, Chenard M, et al: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Proc Natl Acad Sci U S A 92:2730-2734, 1995